Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Accounts Payables (2016 - 2025)

AtriCure (ATRC) has disclosed Accounts Payables for 16 consecutive years, with $25.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Accounts Payables rose 1.11% to $25.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $25.3 million, a 1.11% increase, with the full-year FY2025 number at $25.3 million, up 1.11% from a year prior.
  • Accounts Payables was $25.3 million for Q4 2025 at AtriCure, down from $25.5 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $31.7 million in Q3 2024 to a low of $15.5 million in Q1 2021.
  • A 5-year average of $23.5 million and a median of $24.5 million in 2022 define the central range for Accounts Payables.
  • Peak YoY movement for Accounts Payables: soared 46.02% in 2021, then dropped 19.74% in 2025.
  • AtriCure's Accounts Payables stood at $18.6 million in 2021, then rose by 7.0% to $19.9 million in 2022, then surged by 37.47% to $27.4 million in 2023, then decreased by 8.49% to $25.0 million in 2024, then grew by 1.11% to $25.3 million in 2025.
  • Per Business Quant, the three most recent readings for ATRC's Accounts Payables are $25.3 million (Q4 2025), $25.5 million (Q3 2025), and $25.7 million (Q2 2025).